Video 1 of 3: RNA interference (RNAi) is a naturally occurring process of gene regulation that is already at work inside your body. RNAi therapeutics, which were pioneered by Alnylam,…
Read More »
Alnylam Pharmaceuticals
This video is intended for CEMEA audiences. La PHA est une maladie chronique et invalidante qui a un impact néfaste sur la qualité de vie des patients et de leur…
Read More »
This video is intended for CEMEA audiences. Já neudělám prostě to, co udělá zdravý člověk. Zdravý člověk udělá tu práci za hodinu. Já to dělám třeba dva dny. A jsem…
Read More »
This video was created for UK and Irish audiences. Alnylam is the world’s leading RNA interference (RNAi) company and has pioneered the 2006 Nobel Prize-winning discovery of RNAi into an…
Read More »
This video was created for U.S. audiences. Mary, living with acute intermittent porphyria (AIP), a type of acute hepatic porphyria (AHP), shares how her life has been impacted by the…
Read More »
This video is approved for CEMEA audiences. Para una persona que acaba de ser diagnosticada de porfiria aguda intermitente, mi mensaje sería que no se venga abajo, que no desespere.…
Read More »
This video is intended for CEMEA audiences. AHP ist eine chronische Erkrankung, die das Leben der Patienten und ihrer Angehörigen stark belasten kann. Hören Sie von Eva, wie bei ihr…
Read More »
This video is created for US audiences. In this video Seth, as a combined liver/kidney transplant recipient, discusses his experience with kidney failure and being diagnosed with primary hyperoxaluria type…
Read More »
This video was created for US audiences. Sylvie Le Moal from the Association Française des Malades Atteints de Porphyrie discusses the importance of raising awareness of porphyria, a rare, often…
Read More »
Our core values represent the heart of Alnylam’s culture and how we work together to serve the best interests of patients and our communities. Watch this video to hear employees…
Read More »
